These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36925716)

  • 1. Vascular stiffening in aging females with a hypertension-induced HIF2A gain-of-function mutation.
    Volkova E; Procell L; Kong L; Santhanam L; Gerecht S
    Bioeng Transl Med; 2023 Mar; 8(2):e10403. PubMed ID: 36925716
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chan XY; Volkova E; Eoh J; Black R; Fang L; Gorashi R; Song J; Wang J; Elliott MB; Barreto-Ortiz SF; Chen J; Lin BL; Santhanam L; Cheng L; Lee FS; Prchal JT; Gerecht S
    iScience; 2021 Apr; 24(4):102246. PubMed ID: 33796838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension.
    Zhu J; Zhao L; Hu Y; Cui G; Luo A; Bao C; Han Y; Zhou T; Lu W; Wang J; Black SM; Tang H
    Front Cell Dev Biol; 2021; 9():701247. PubMed ID: 34422822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.
    Tan Q; Kerestes H; Percy MJ; Pietrofesa R; Chen L; Khurana TS; Christofidou-Solomidou M; Lappin TR; Lee FS
    J Biol Chem; 2013 Jun; 288(24):17134-44. PubMed ID: 23640890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untangling the mechanisms of pulmonary arterial hypertension-induced right ventricular stiffening in a large animal model.
    Kakaletsis S; Malinowski M; Snider JC; Mathur M; Sugerman GP; Luci JJ; Kostelnik CJ; Jazwiec T; Bersi MR; Timek TA; Rausch MK
    Acta Biomater; 2023 Nov; 171():155-165. PubMed ID: 37797706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.
    Dai Z; Zhu MM; Peng Y; Machireddy N; Evans CE; Machado R; Zhang X; Zhao YY
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1423-1434. PubMed ID: 29924941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Kudryashova TV; Dabral S; Nayakanti S; Ray A; Goncharov DA; Avolio T; Shen Y; Rode A; Pena A; Jiang L; Lin D; Baust J; Bachman TN; Graumann J; Ruppert C; Guenther A; Schmoranzer M; Grobs Y; Eve Lemay S; Tremblay E; Breuils-Bonnet S; Boucherat O; Mora AL; DeLisser H; Zhao J; Zhao Y; Bonnet S; Seeger W; Pullamsetti SS; Goncharova EA
    Circ Res; 2022 Mar; 130(5):760-778. PubMed ID: 35124974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male.
    Toyoda H; Hirayama J; Sugimoto Y; Uchida K; Ohishi K; Hirayama M; Komada Y
    Pediatrics; 2014 Jun; 133(6):e1787-91. PubMed ID: 24819565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension.
    Liu A; Tian L; Golob M; Eickhoff JC; Boston M; Chesler NC
    Hypertension; 2015 Nov; 66(5):1082-8. PubMed ID: 26418020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
    Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P
    J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
    Jia D; He Y; Zhu Q; Liu H; Zuo C; Chen G; Yu Y; Lu A
    Cardiovasc Res; 2017 May; 113(6):586-597. PubMed ID: 28407046
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
    Hu CJ; Poth JM; Zhang H; Flockton A; Laux A; Kumar S; McKeon B; Mouradian G; Li M; Riddle S; Pugliese SC; Brown RD; Wallace EM; Graham BB; Frid MG; Stenmark KR
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Altitude Andean H194R HIF2A Allele Is a Hypomorphic Allele.
    Jorgensen K; Song D; Weinstein J; Garcia OA; Pearson LN; Inclán M; Rivera-Chira M; León-Velarde F; Kiyamu M; Brutsaert TD; Bigham AW; Lee FS
    Mol Biol Evol; 2023 Jul; 40(7):. PubMed ID: 37463421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
    Fliedner SM; Shankavaram U; Marzouca G; Elkahloun A; Jochmanova I; Daerr R; Linehan WM; Timmers H; Tischler AS; Papaspyrou K; Brieger J; de Krijger R; Breza J; Eisenhofer G; Zhuang Z; Lehnert H; Pacak K
    Neoplasia; 2016 Sep; 18(9):567-76. PubMed ID: 27659016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension.
    Sun W; Chan SY
    Front Med (Lausanne); 2018; 5():204. PubMed ID: 30073166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction.
    Labrousse-Arias D; Castillo-González R; Rogers NM; Torres-Capelli M; Barreira B; Aragonés J; Cogolludo Á; Isenberg JS; Calzada MJ
    Cardiovasc Res; 2016 Jan; 109(1):115-30. PubMed ID: 26503986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.